Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in Early Parkinson's Disease
NCT01280123Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Mar 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in Parkinson's disease (PD), sponsored by University of Rochester. Started Mar 2011; status: completed.
02
Drugs
pioglitazone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01280123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01280123.